BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (SUNRISE PHARMACEUTICAL, INC)
Welcome to the PulseAid listing for the BUTALBITAL, ACETAMINOPHEN AND CAFFEINE drug offered from SUNRISE PHARMACEUTICAL, INC. This Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Barbiturate [EPC],Barbiturates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | SUNRISE PHARMACEUTICAL, INC |
| NON-PROPRIETARY NAME: | butalbital, acetaminophen and caffeine |
| SUBSTANCE NAME: | ACETAMINOPHEN; CAFFEINE; BUTALBITAL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Barbiturate [EPC],Barbiturates [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-01-10 |
| END MARKETING DATE: | 0000-00-00 |
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE HUMAN PRESCRIPTION DRUG Details:
| Item Description | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE from SUNRISE PHARMACEUTICAL, INC |
| LABELER NAME: | SUNRISE PHARMACEUTICAL, INC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300; 40; 50(mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2017-01-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 11534-187_2ae0eed4-d732-4087-a1d0-17684f6077ee |
| PRODUCT NDC: | 11534-187 |
| APPLICATION NUMBER: | ANDA207118 |
Other ACETAMINOPHEN; CAFFEINE; BUTALBITAL Pharmaceutical Manufacturers / Labelers:
